留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

孕期血脂水平与子代3岁儿童超重肥胖风险的关联

张丽芳 何兆聪 韦冬梅 卢锦华 旷雅舒 陆敏珊 邵丹彤 邱琇 何健荣

张丽芳, 何兆聪, 韦冬梅, 卢锦华, 旷雅舒, 陆敏珊, 邵丹彤, 邱琇, 何健荣. 孕期血脂水平与子代3岁儿童超重肥胖风险的关联[J]. 中国学校卫生, 2025, 46(8): 1074-1078. doi: 10.16835/j.cnki.1000-9817.2025237
引用本文: 张丽芳, 何兆聪, 韦冬梅, 卢锦华, 旷雅舒, 陆敏珊, 邵丹彤, 邱琇, 何健荣. 孕期血脂水平与子代3岁儿童超重肥胖风险的关联[J]. 中国学校卫生, 2025, 46(8): 1074-1078. doi: 10.16835/j.cnki.1000-9817.2025237
ZHANG Lifang, HE Zhaocong, WEI Dongmei, LU Jinhua, KUANG Yashu, LU Minshan, SHAO Dantong, QIU Xiu, HE Jianrong. Association between maternal lipids during pregnancy and risk of offspring's overweight and obesity at 3 years of age[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(8): 1074-1078. doi: 10.16835/j.cnki.1000-9817.2025237
Citation: ZHANG Lifang, HE Zhaocong, WEI Dongmei, LU Jinhua, KUANG Yashu, LU Minshan, SHAO Dantong, QIU Xiu, HE Jianrong. Association between maternal lipids during pregnancy and risk of offspring's overweight and obesity at 3 years of age[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(8): 1074-1078. doi: 10.16835/j.cnki.1000-9817.2025237

孕期血脂水平与子代3岁儿童超重肥胖风险的关联

doi: 10.16835/j.cnki.1000-9817.2025237
基金项目: 

国家自然科学基金项目 82273642

国家自然科学基金项目 82461160320

国家自然科学基金项目 82173525

国家自然科学基金项目 82404262

广东省基础与应用基础研究基金项目 2022A1515220104

广州市科技局项目 202201020656

广州市科技局项目 20231A011044

详细信息
    作者简介:

    张丽芳(1988-),女,广西北海人,硕士,主治医师,主要研究方向为妇幼健康流行病学

    何兆聪(1998-),男,广东佛山人,在读硕士,主要研究方向为妇幼健康流行病学

    通讯作者:

    邱琇,E-mail:xiu.qiu@bigcs.org

    何健荣,E-mail: jianrong.he@bigcs.org

  • 利益冲突声明  所有作者声明无利益冲突。
  • 张丽芳和何兆聪为共同第一作者。
  • 中图分类号: R179 R723.14 R715.3

Association between maternal lipids during pregnancy and risk of offspring's overweight and obesity at 3 years of age

  • 摘要:   目的  探讨孕期血脂水平与子代3岁儿童超重肥胖风险的关联,为儿童肥胖防控提供科学依据。  方法  纳入截至2021年9月广州出生队列研究中有孕期血脂检测以及子代3岁时体格生长数据的2 432对母子。孕13~19+6周(孕中期)和孕32~39+6周(孕晚期)的血脂指标包括高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)、胆固醇(TC)。根据世界卫生组织5岁以下儿童生长标准,计算儿童年龄别体质量指数(BMI)Z评分;并以血脂Z分按四分位数分为Q1、Q2、Q3和Q4四组。采用线性回归分析孕期血脂水平与子代3岁时BMI Z分的关系,采用稳健Poisson回归评估母亲孕期血脂水平与子代3岁儿童超重肥胖风险的关联,模型均控制母亲受孕年龄、受教育程度、产次、孕前BMI和妊娠期糖尿病等因素。  结果  不同母亲孕前BMI的儿童超重肥胖风险检出率差异有统计学意义(χ2=22.85,P < 0.01)。线性回归分析结果显示,孕晚期TG Z分与子代3岁BMI Z分呈正相关(β=0.10,95%CI=0.02~0.18,P < 0.05)。稳健Poisson回归分析结果显示,与孕中期TC Q1组相比,孕中期Q4组与子代3岁时超重肥胖风险升高相关(RR=1.59,95%CI=1.04~2.44);与孕晚期TG Q1组相比,孕晚期Q4组增加子代3岁时超重肥胖风险(RR=1.79,95%CI=1.02~3.12)(P值均 < 0.05)。  结论  孕中期母亲血清TC水平升高会增加子代3岁时的超重肥胖风险,孕晚期母亲血清TG水平与子代3岁时BMI和超重肥胖风险呈正相关。
    1)  利益冲突声明  所有作者声明无利益冲突。
    2)  张丽芳和何兆聪为共同第一作者。
  • 表  1  不同组别子代3岁儿童超重肥胖风险检出率比较

    Table  1.   Comparison of detection rates of overweight and obesity risk in offspring age 3 years old among different groups

    组别 人数 超重肥胖风险人数 χ2 P
    母亲受教育程度
      高中及以下 192 21(10.93) 2.82 0.42
      大专/专科 583 54(9.26)
      本科 1 325 119(8.98)
      研究生及以上 332 39(11.75)
    母亲产次
      初产妇 1 917 179(9.34) 0.51*
      经产妇 514 53(10.31)
      缺失 1 1(100.00)
    母亲孕前BMI
      正常 1 580 156(9.87) 22.85 < 0.01
      消瘦 508 27(5.31)
      超重 242 39(16.12)
      肥胖 50 5(10.00)
      缺失 52 6(11.54)
    母亲GDM
      否 2 066 196(9.49) 0.66*
      是 362 37(10.22)
      缺失 4 0
    儿童性别
      男 1 262 125(9.90) 0.32 0.57
      女 1 170 108(9.23)
    注: ()内数字为检出率/%;*为Fisher检验。
    下载: 导出CSV

    表  2  孕期血脂水平与子代3岁儿童BMI Z分的线性回归分析

    Table  2.   Linear regression analysis of maternal lipids during pregnancy and BMI Z score in offspring aged 3 years children

    孕周 自变量 人数 模型1 模型2
    β值(95%CI) P β值(95%CI) P
    13~19+6 HDL-C 1 586 -0.03(-0.08~0.02) 0.18 0.01(-0.04~0.06) 0.83
    LDL-C 1 584 -0.02(-0.07~0.03) 0.51 -0.03(-0.08~0.02) 0.22
    TC 1 586 -0.00(-0.05~0.05) 0.91 -0.01(-0.05~0.04) 0.85
    TG 1 584 0.08(0.03~0.13) < 0.01 0.05(-0.01~0.10) 0.09
    32~39+6 HDL-C 955 -0.06(-0.12~0.01) 0.10 -0.04(-0.10~0.03) 0.30
    LDL-C 956 -0.07(-0.13~-0.01) 0.04 -0.05(-0.11~0.02) 0.15
    TC 956 -0.02(-0.08~0.05) 0.61 0.01(-0.06~0.07) 0.82
    TG 949 0.13(0.05~0.21) < 0.01 0.10(0.02~0.18) 0.02
    注:模型1为未校正模型,模型2调整母亲受孕年龄、受教育程度、产次、孕前BMI、GDM等混杂因素。
    下载: 导出CSV

    表  3  孕期血脂水平与子代3岁儿童超重肥胖风险关联的稳健Poisson回归分析

    Table  3.   Poisson regression with robust error variance the association between maternal lipids during pregnancy and risk of overweight or obesity in offspring aged 3 years child

    孕周 自变量 人数 模型1 模型2
    Q2 Q3 Q4 Q2 Q3 Q4
    13~19+6 HDL-C 1 586 0.71(0.44~1.14) 0.91(0.59~1.42) 0.96(0.62~1.48) 0.76(0.47~1.22) 1.04(0.66~1.64) 1.16(0.74~1.82)
    LDL-C 1 584 1.00(0.62~1.59) 1.13(0.72~1.78) 1.09(0.69~1.73) 0.97(0.60~1.54) 1.15(0.73~1.81) 1.00(0.63~1.59)
    TC 1 586 1.16(0.73~1.86) 0.74(0.44~1.27) 1.61(1.04~2.48)* 1.15(0.72~1.84) 0.73(0.42~1.25) 1.59(1.04~2.44)*
    TG 1 584 0.92(0.56~1.53) 1.49(0.95~2.34) 1.24(0.78~1.98) 0.91(0.55~1.49) 1.36(0.86~2.15) 1.05(0.65~1.70)
    32~39+6 HDL-C 955 1.20(0.72~2.01) 1.15(0.68~1.93) 1.23(0.74~2.06) 1.15(0.68~1.95) 1.20(0.72~2.01) 1.26(0.75~2.13)
    LDL-C 956 0.85(0.53~1.38) 0.75(0.46~1.24) 0.79(0.48~1.28) 0.89(0.55~1.43) 0.83(0.50~1.38) 0.84(0.50~1.42)
    TC 956 1.25(0.76~2.05) 0.96(0.57~1.64) 1.13(0.68~1.87) 1.26(0.77~2.07) 0.98(0.57~1.69) 1.16(0.68~1.98)
    TG 949 1.33(0.75~2.35) 1.43(0.82~2.51) 1.86(1.09~3.15)* 1.42(0.79~2.57) 1.38(0.75~2.53) 1.79(1.02~3.12)*
    注:模型1为未校正模型,模型2调整母亲受孕年龄、受教育程度、产次、孕前BMI、GDM等混杂因素;*P < 0.05。
    下载: 导出CSV
  • [1] PAN X F, WANG L, PAN A. Epidemiology and determinants of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(6): 373-392. doi: 10.1016/S2213-8587(21)00045-0
    [2] WANG Y, ZHAO L, GAO L, et al. Health policy and public health implications of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(7): 446-461. doi: 10.1016/S2213-8587(21)00118-2
    [3] JEBEILE H, KELLY A S, O'MALLEY G, et al. Obesity in children and adolescents: epidemiology, causes, assessment, and management[J]. Lancet Diabetes Endocrinol, 2022, 10(5): 351-365. doi: 10.1016/S2213-8587(22)00047-X
    [4] LARQUÉ E, LABAYEN I, FLODMARK C E, et al. From conception to infancy-early risk factors for childhood obesity[J]. Nat Rev Endocrinol, 2019, 15(8): 456-478. doi: 10.1038/s41574-019-0219-1
    [5] MARTIN C L, VLADUTIU C J, ZIKRY T M, et al. Maternal lipid levels during pregnancy and child weight status at 3 years of age[J]. Pediatr Obes, 2019, 14(4): e12485. doi: 10.1111/ijpo.12485
    [6] BAAS R E, HUTTEN B A, HENRICHS J, et al. Associations between maternal lipid blood levels at the 13th week of pregnancy and offspring's adiposity at age 11-12 years[J]. J Clin Endocrinol Metab, 2022, 107(10): e4048-e4057. doi: 10.1210/clinem/dgac442
    [7] THAWARE P K, MCKENNA S, PATTERSON C C, et al. Maternal lipids at 28 weeks' gestation and offspring adiposity at age 5 to 7 years[J]. J Clin Endocrinol Metab, 2018, 103(10): 3767-3772. doi: 10.1210/jc.2018-00786
    [8] YELVERTON C A, O'KEEFFE L M, BARTELS H C, et al. Association between maternal blood lipids during pregnancy and offspring growth trajectories in a predominantly macrosomic cohort: findings from the ROLO longitudinal birth cohort study[J]. Eur J Pediatr, 2023, 182(12): 5625-5635. doi: 10.1007/s00431-023-05251-2
    [9] BLANCO S E, TUOMAALA A K, TABASSUM R, et al. Early ascending growth is associated with maternal lipoprotein profile during mid and late pregnancy and in cord blood[J]. Int J Obes, 2023, 47(11): 1081-1087. doi: 10.1038/s41366-023-01361-x
    [10] ØYRI L K L, CHRISTENSEN J J, SEBERT S, et al. Maternal prenatal cholesterol levels predict offspring weight trajectories during childhood in the Norwegian mother, father and child cohort study[J]. BMC Med, 2023, 21(1): 43. doi: 10.1186/s12916-023-02742-9
    [11] WAAGE C W, MDALA I, STIGUM H, et al. Lipid and lipoprotein concentrations during pregnancy and associations with ethnicity[J]. BMC Pregnancy Childbirth, 2022, 22(1): 246. doi: 10.1186/s12884-022-04524-2
    [12] American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1): S13-S28.
    [13] WHO Multicentre Growth Reference Study Group. WHO child growth standards based on length/height, weight and age[J]. Acta Paediatr Suppl, 2006, 450: 76-85.
    [14] WHO. WHO child growth standards: training course on child growth assessment[EB/OL]. (2008-12-01)[2025-02-28]. https://www.who.int/publications/i/item/9789241595070.
    [15] ROLLAND-CACHERA M F. Childhood obesity: current definitions and recommendations for their use[J]. Int J Pediatr Obes, 2011, 6(5/6): 325-331.
    [16] LISTER N B, BAUR L A, FELIX J F, et al. Child and adolescent obesity[J]. Nat Rev Dis Prim, 2023, 9(1): 24. doi: 10.1038/s41572-023-00435-4
    [17] WOO BAIDAL J A, LOCKS L M, CHENG E R, et al. Risk factors for childhood obesity in the first 1 000 days: a systematic review[J]. Am J Prev Med, 2016, 50(6): 761-779. doi: 10.1016/j.amepre.2015.11.012
    [18] CASTELLANO B M, THELEN A M, MOLDAVSKI O, et al. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex[J]. Science, 2017, 355(6331): 1306-1311. doi: 10.1126/science.aag1417
    [19] PANWAR V, SINGH A, BHATT M, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease[J]. Signal Transduct Target Ther, 2023, 8(1): 375. doi: 10.1038/s41392-023-01608-z
    [20] DONG J, SHIN N, CHEN S, et al. Is there a definite relationship between placental mTOR signaling and fetal growth?[J]. Biol Reprod, 2020, 103(3): 471-486. doi: 10.1093/biolre/ioaa070
    [21] DESOYE G, HERRERA E. Adipose tissue development and lipid metabolism in the human fetus: the 2020 perspective focusing on maternal diabetes and obesity[J]. Prog Lipid Res, 2021, 81: 101082. doi: 10.1016/j.plipres.2020.101082
    [22] WALDROP S W, NIEMIEC S, WOOD C, et al. Cord blood DNA methylation of immune and lipid metabolism genes is associated with maternal triglycerides and child adiposity[J]. Obesity (Silver Spring), 2024, 32(1): 187-199. doi: 10.1002/oby.23915
  • 加载中
表(3)
计量
  • 文章访问数:  12
  • HTML全文浏览量:  6
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-01-02
  • 修回日期:  2025-02-28
  • 网络出版日期:  2025-08-30
  • 刊出日期:  2025-08-25

目录

    /

    返回文章
    返回